Oncotarget

Research Papers:

Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information

Zhenyu Yue, Hai-Tao Li, Yabing Yang, Sajid Hussain, Chun-Hou Zheng, Junfeng Xia and Yan Chen _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:36092-36100. https://doi.org/10.18632/oncotarget.9132

Metrics: PDF 3056 views  |   HTML 2913 views  |   ?  


Abstract

Zhenyu Yue1,2, Hai-Tao Li3, Yabing Yang1, Sajid Hussain1, Chun-Hou Zheng3, Junfeng Xia2, Yan Chen1

1School of Life Sciences, Anhui University, Hefei, Anhui 230601, China

2Institute of Health Sciences, Anhui University, Hefei, Anhui 230601, China

3College of Electrical Engineering and Automation, Anhui University, Hefei, Anhui 230601, China

Correspondence to:

Yan Chen, email: [email protected]

Junfeng Xia, email: [email protected]

Keywords: breast cancer, gene co-expression, protein-protein interaction, subnetwork extraction algorithm, candidate gene

Received: October 31, 2015     Accepted: April 16, 2016     Published: May 02, 2016

ABSTRACT

Breast cancer (BC) is one of the most common malignancies that could threaten female health. As the molecular mechanism of BC has not yet been completely discovered, identification of related genes of this disease is an important area of research that could provide new insights into gene function as well as potential treatment targets. Here we used subnetwork extraction algorithms to identify novel BC related genes based on the known BC genes (seed genes), gene co-expression profiles and protein-protein interaction network. We computationally predicted seven key genes (EPHX2, GHRH, PPYR1, ALPP, KNG1, GSK3A and TRIT1) as putative genes of BC. Further analysis shows that six of these have been reported as breast cancer associated genes, and one (PPYR1) as cancer associated gene. Lastly, we developed an expression signature using these seven key genes which significantly stratified 1660 BC patients according to relapse free survival (hazard ratio [HR], 0.55; 95% confidence interval [CI], 0.46–0.65; Logrank p = 5.5e−13). The 7-genes signature could be established as a useful predictor of disease prognosis in BC patients. Overall, the identified seven genes might be useful prognostic and predictive molecular markers to predict the clinical outcome of BC patients.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9132